Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonists

被引:28
作者
Keenan, RM [1 ]
Miller, WH [1 ]
Lago, MA [1 ]
Ali, FE [1 ]
Bondinell, WE [1 ]
Callahan, JF [1 ]
Calvo, RR [1 ]
Cousins, RD [1 ]
Hwang, SM [1 ]
Jakas, DR [1 ]
Ku, TW [1 ]
Kwon, C [1 ]
Nguyen, TT [1 ]
Reader, VA [1 ]
Rieman, DJ [1 ]
Ross, ST [1 ]
Takata, DT [1 ]
Uzinskas, IN [1 ]
Yuan, CCK [1 ]
Smith, BR [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Div Res & Dev, Collegeville, PA 19426 USA
关键词
D O I
10.1016/S0960-894X(98)00555-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In a 3-oxo-1,4-benzodiazepine-2-acetic acid series of vitronectin receptor (alpha v beta 3) antagonists containing a benzimidazole as a novel arginine mimetic, we examined the effects of benzimidazole modifications and amide substitutions on both activity and pharmacokinetics. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3165 / 3170
页数:6
相关论文
共 11 条
[1]   CONFORMATIONALLY CONSTRAINED PEPTIDES AND SEMIPEPTIDES DERIVED FROM RGD AS POTENT INHIBITORS OF THE PLATELET FIBRINOGEN RECEPTOR AND PLATELET-AGGREGATION [J].
ALI, FE ;
BENNETT, DB ;
CALVO, RR ;
ELLIOTT, JD ;
HWANG, SM ;
KU, TW ;
LAGO, MA ;
NICHOLS, AJ ;
ROMOFF, TT ;
SHAH, DH ;
VASKO, JA ;
WONG, AS ;
YELLIN, TO ;
YUAN, CK ;
SAMANEN, JM .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) :769-780
[2]   Discovery of potent nonpeptide vitronectin receptor (alpha(v)beta(3)) antagonists [J].
Keenan, RM ;
Miller, WH ;
Kwon, C ;
Ali, FE ;
Callahan, JF ;
Calvo, RR ;
Hwang, SM ;
Kopple, KD ;
Peishoff, CE ;
Samanen, JM ;
Wong, AS ;
Yuan, CK ;
Huffman, WF .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (15) :2289-2292
[3]  
KEENAN RM, 1998, BIOORG MED CHEM LETT, V8
[4]   An alternate enantiospecific synthesis of methyl (S)-7-tert-butoxycarbonyl-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetate [J].
Ku, TW ;
Ali, FE ;
Bondinell, WE ;
Erhard, KF ;
Huffman, WF ;
Venslavsky, JW ;
Yuan, CCK .
TETRAHEDRON LETTERS, 1997, 38 (18) :3131-3134
[5]   POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS WHICH PRESENT AN ALTERNATIVE PHARMACOPHORE [J].
KU, TW ;
MILLER, WH ;
BONDINELL, WE ;
ERHARD, KF ;
KEENAN, RM ;
NICHOLS, AJ ;
PEISHOFF, CE ;
SAMANEN, JM ;
WONG, AS ;
HUFFMAN, WF .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) :9-12
[6]   Cloning and characterization of a novel integrin beta(3) subunit [J].
Kumar, CS ;
James, IE ;
Wong, A ;
Mwangi, V ;
Feild, JA ;
Nuthulaganti, P ;
Connor, JR ;
Eichman, C ;
Ali, F ;
Hwang, SM ;
Rieman, DJ ;
Drake, FH ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16390-16397
[7]   Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist [J].
Miller, WH ;
Ku, TW ;
Ali, FE ;
Bondinell, WE ;
Calvo, RR ;
Davis, LD ;
Erhard, KF ;
Hall, LB ;
Huffman, WF ;
Keenan, RM ;
Kwon, C ;
Newlander, KA ;
Ross, ST ;
Samanen, JM ;
Takata, DT ;
Yuan, CK .
TETRAHEDRON LETTERS, 1995, 36 (52) :9433-9436
[8]   SYNTHESIS OF A NOVEL CLASS OF HETEROAROMATIC AMINO-ACIDS AND THEIR USE IN THE PREPARATION OF ANALOGS OF LUTEINIZING-HORMONE-RELEASING HORMONE [J].
NESTOR, JJ ;
HORNER, BL ;
HO, TL ;
JONES, GH ;
MCRAE, GI ;
VICKERY, BH .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) :320-325
[9]   GPIIb/IIIa antagonists [J].
Samanen, J .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 :91-100
[10]  
Samanen J, 1997, CURR PHARM DESIGN, V3, P545